ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

24,149Medicare Part D Prescriptions Filled, Including Refills

Rank: 36 out of 2061

$1.44M Total Retail Price of All Prescriptions

Rank: 34 out of 2061

629 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
67% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 629 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

16% of this provider’s 629 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 16,833 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
SIMVASTATIN 974 709 1 1
LISINOPRIL 963 620 2 2
LEVOTHYROXINE SODIUM 907 739 3 3
OMEPRAZOLE 766 536 4 5
FUROSEMIDE 618 462 5 6
METFORMIN HCL 548 348 6 9
AMLODIPINE BESYLATE 500 364 7 4
WARFARIN SODIUM 484 379 8 11
METOPROLOL TARTRATE 438 329 9 7
HYDROCODONE-ACETAMINOPHEN 437 354 S3 10 10
JANTOVEN 380 289 11 93
POTASSIUM CHLORIDE 365 287 12 16
TRAMADOL HCL 337 216 13 18
PRAVASTATIN SODIUM 303 187 14 14
ATORVASTATIN CALCIUM 303 228 14 8
CITALOPRAM HBR 276 219 16 20
OXYCODONE-ACETAMINOPHEN 267 160 S2 17 36
NAMENDA 260 251 18 37
DONEPEZIL HCL 252 242 19 24
CARVEDILOL 247 175 20 22
HYDROCHLOROTHIAZIDE 245 152 21 12
CLOPIDOGREL 240 191 22 29
GABAPENTIN 240 120 22 15
ATENOLOL 219 87 24 13
ZOLPIDEM TARTRATE 216 140 25 23
SERTRALINE HCL 202 157 26 21
PROAIR HFA 199 129 27 40
SINGULAIR 194 92 28 88
SPIRIVA 191 88 29 63
AZITHROMYCIN 182 136 30 34
GLIMEPIRIDE 180 145 31 33
PLAVIX 173 144 32 49
RISPERIDONE 163 119 33 66
ALENDRONATE SODIUM 162 142 34 25
IBUPROFEN 160 81 35 90
NEXIUM 159 79 36 26
CRESTOR 158 123 37 31
CIPROFLOXACIN HCL 154 112 38 54
CYCLOBENZAPRINE HCL 152 45 R 39 78
METOPROLOL SUCCINATE 148 108 40 19
ALLOPURINOL 147 131 41 28
KLOR-CON M20 130 104 42 47
IPRATROPIUM-ALBUTEROL 129 85 43 117
PAROXETINE HCL 129 110 43 61
DIGOXIN 127 104 45 56
FENOFIBRATE 123 69 46 65
CLONIDINE HCL 122 106 47 52
OXYBUTYNIN CHLORIDE ER 113 79 48 80
LOSARTAN POTASSIUM 112 73 49 17
PROMETHAZINE HCL 112 60 R 49 119
ISOSORBIDE MONONITRATE ER 108 80 51 42
LISINOPRIL-HYDROCHLOROTHIAZIDE 107 83 52 27
DIVALPROEX SODIUM 106 75 53 74
TRAZODONE HCL 103 59 54 39
DILTIAZEM 24HR ER 103 88 54 108
MONTELUKAST SODIUM 103 66 54 176
SYMBICORT 99 55 57 158
ACTOS 99 34 57 140
LEVETIRACETAM 98 85 59 102
GEMFIBROZIL 97 78 60 107
JANUVIA 97 30 60 51
PANTOPRAZOLE SODIUM 96 72 62 45
LANTUS SOLOSTAR 94 74 63 76
NIASPAN 94 27 63 155
NOVOLOG 93 67 65 102
TRIAMTERENE-HCTZ 93 47 65 38
EXELON 91 91 67 94
ADVAIR DISKUS 90 49 68 57
ZETIA 89 50 69 68
ESCITALOPRAM OXALATE 88 69 70 77
RANITIDINE HCL 88 32 70 53
METFORMIN HCL ER 88 62 70 71
LANTUS 85 55 73 48
TAMSULOSIN HCL 85 67 73 30
LIPITOR 84 57 75 70
VERAPAMIL ER 81 68 76 100
NAPROXEN 81 46 76 110
FLUTICASONE PROPIONATE 81 43 76 43
LYRICA 79 37 79 83
CARBIDOPA-LEVODOPA 79 69 79 97
PEN NEEDLE 77 46 81 116
MIRTAZAPINE 77 72 81 46
DILTIAZEM 24HR CD 76 73 83 118
VENLAFAXINE HCL ER 75 20 84 109
KLOR-CON M10 75 72 84 125
AMITRIPTYLINE HCL 74 70 R 86 89
FLUOXETINE HCL 74 38 86 73
PREDNISONE 74 37 86 32
FLUPHENAZINE HCL 73 62 89 327
POLYETHYLENE GLYCOL 3350 72 61 90 64
DIOVAN 72 59 90 41
CELEBREX 70 44 92 91
BENZTROPINE MESYLATE 68 11 R 93 149
METHYLPREDNISOLONE 68 55 93 101
CEFUROXIME 66 62 95 170
METOCLOPRAMIDE HCL 65 20 96 138
BENICAR 63 63 97 175
ENOXAPARIN SODIUM 61 43 98 267
MEGESTROL ACETATE 59 57 R 99 198
JANUMET 59 44 99 180
NYSTATIN 58 41 101 148
HYDRALAZINE HCL 57 49 102 69
FINASTERIDE 56 44 103 86
CYMBALTA 56 37 103 59
LOSARTAN-HYDROCHLOROTHIAZIDE 56 56 103 50
ACTONEL 55 55 106 231
NITROFURANTOIN MONO-MACRO 55 45 106 162
FAMOTIDINE 54 50 108 67
PHENYTOIN SODIUM EXTENDED 53 22 109 145
CILOSTAZOL 53 31 109 189
ACETAMINOPHEN-CODEINE 53 46 S3 109 144
BENICAR HCT 52 52 112 217
SUCRALFATE 51 38 113 151
COUMADIN 50 50 114 218
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 8, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.